|
 |

|
Jacek Bielawski, Ph.D.
Research Associate Professor |
| |
|
|
| |
2001 |
Associate
Professor, Department of Biochemistry & Molecular Biology
Medical University of South Carolina, Charleston, SC |
| |
1996-2001 |
Senior
Scientist, Glaxo-Wellcome, Research Triangle Park, NC |
| |
1993-1996 |
R&D Senior
Chemist, Southern Testing and Research Labs, Wilson, NC |
| |
1989-1993 |
Quality
Assurance, Triangle Labs, Research Triangle Park, NC |
| |
1987-1989 |
Environmental
Chemist, NC Department of Health and Natural Resources |
| |
1985-1987 |
Research
Associate, University of California at Berkeley |
| |
1984-1985 |
Research Associate,
University of Kentucky at Lexington, Lexington, KY |
| |
1977-1984 |
Assistant Professor,
Technical University of Wroclaw, Wroclaw, Poland |
| |
1975-1977 |
Research Technical
Associate, Technical University of Wroclaw, Wroclaw,
Poland |
| |
1975 |
Ph.D.,
Technical University of Wroclaw, Wroclaw, Poland |
| |
1969 |
M.S.,
Technical University of Wroclaw, Wroclaw, Poland |
|

Office: 843-792-1529
Lab: 843-792-1529
Fax: 843-792-4850
Email: bielawsj@musc.edu
BSB-752 |
|
| |
|
| |
Research Interests |
| |
During the
academic tenure, my research has focused on synthetic and
analytical chemistry of pesticides. New synthetic methods for
the preparation of heterocyclic compounds with oxygen, sulfur,
nitrogen and boron have been developed. A large number of new
pesticides, as well as their radiolabeled analogues, have been
synthesized to investigate structure/activity relationship,
metabolism and mode of action. My research has also included
extensive work in analytical chemistry of pesticides, data
interpretation and structure determination using GC, GC/MS,
HRGC/HRMS, HPLC, LC/MS, TLC, FAA, GFAA, ICP, multinuclear NMR,
IR, and UV/VIS techniques. Most recently, I have
performed analysis of new drugs and their metabolites in
biological tissues by HPLC, LC/MS and RIA, and have provided
analytical support of new drugs for Brain Blood Barrier,
Gastrointestinal Absorption and Pharmacokinetic studies.
Studies have involved development and validation of the
protocols for analysis of a large number of experimental drugs
from "in vitro" and "in vivo" experiments by
HPLC, LC/MS, LC/MS-MS and RIA methods. I have also developed
and validated generic screens for plasma protein binding and
in "in vitro" metabolic stability. My work has also
involved development of new, or improvement of existing,
analytical methods for determination of trace residues of
pesticides and drugs, their intermediates and metabolites as
well as priority polluntants in a variety of matrices.
In my future research, I will concentrate on the role of
sphingolipids in signal transduction and cell regulation in
cancer biology. Sphingolipid metabolism assumes a key role in
the complex mechanisms regulating cellular stress responses to
environmental inducers. Several sphingolipid metabolites have
recently been shown to have bioactivity, and their individual
contributions to the regulatory pathways that govern cell
growth are currently being established. The Sphingomyelin (SM)
cycle, a ubiquitous signaling system linking a specific set of
cell-surface receptors to the nucleus and cellular events,
represents a novel antiproliferative signal transduction
pathway that regulates cell cycle arrest, differentiation, and
apoptosis. Ceramide, the putative second messenger of the SM
cycle, has been proposed as a molecular sensor of injury and
assumes a fundamental role in the cellular stress response.
This discovery has created the need to examine changes in
sphingolipid metabolism and composition (especially ceramide),
and offers promises for new molecular insights into tumor
growth and metastasis. Using my strong background in synthetic
and analytical chemistry, I will focus on establishing a
state-of-the-art analytical facility to support this research.
My goal is to develop insight into the mechanism of action of
sphingolipids through the data generated by well established
analytical foundation. Development of new, mostly LC/MS
analytical protocols, will provide medical investigators with
the powerful tools to monitor changes in sphingolipid/lipid
composition in normal and cancer environments and will provide
one of the missing linkages in the search for effective
therapy. |
|
| |
Selected Publications |
| |
- Bielawski, J.,
Morgan, D.G., Smith, G.A., and Lloyd, F.W. (2001)
Simultaneous Determination of Uracil and Dihydrouracil in
Human Serum by Liquid/Liquid Extraction and Supercritical
Fluid Chromatography with Mass Spectral Detection. J.
Chrom. (In press)
- Bielawski, J. and
Casida, J.E. (1987) Phosphorylating Intermediates in the
Peracid Oxidation of Phosphorothionates, Phosphorothiolates
and Phosphorodithioates. J. Agric. Food Chem., 36:
610-619.
- Bielawski, J. and
Niedenzu, K. (1986) Reaction of Boroxines and Diborozanes
with Pyrazole. Inorganic Chem., 25: 1771-1778.
- Bielawski, J.,
Hodgkins, T.G., Leyton, W.J., Niedenzu, K., Niedenzu, P.M.,
and Trofimenko, S. (1986) Polynuclear Pyrazoyl-Bridged Spiro
Species Containing Boron and Metal Centers. Inorganic
Chem., 25: 87-93.
- Bielawski, J. and
Niedenzu, K. (1986) Triply Bridged Diboron Species of the
Pyrazabole Type. Inorganic Chem., 25: 85-89.
- Bielawski, J.,
Niedenzu, K. and Steward, J.S. (1985) Preparation and
Characterization of Some Isoelectronic Boron-Nitrogen
Analogs of Substituted Uracil. Z. Naturforsch., 40B:
389-394.
- Witek, S., Bielawska, A.,
Bielawski, J. (1973)
|
|
|
| |
|
|